Gene · 25913
NIH grants1,830
NIH grants whose papers are about the gene, through NIH's grant-paper links.
841 to 860 of 1,830
Download this page as JSON| Grant | Title | POT1 papers | Newest fiscal year |
|---|---|---|---|
| R01GM112864 | Mechanisms of fork restart in response to genotoxic stress | 5 | 2018 |
| R15GM123443 | Influence of small molecules on G-quadruplex stability, folding kinetics, and interactions with proteins | 5 | 2018 |
| P50CA127297 | SPORE in Pancreatic Cancer | 4 | 2018 |
| R01GM048123 | Structure and Function of Human Telomerase | 4 | 2018 |
| U10CA180861 | ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie | 4 | 2018 |
| R01CA129537 | Chromatin modifying factors control radiation response and genomic stability | 3 | 2018 |
| R01GM076388 | Regulation of the ATR Checkpoint Kinase by DNA Damage | 3 | 2018 |
| R01GM077509 | Roles of Ku and its interaction partners in telomere function and DNA repair | 3 | 2018 |
| T32CA009673 | Cancer Biology Training Program | 3 | 2018 |
| F32HL142207 | Mechanisms of telomerase RNA insufficiency in familial pulmonary fibrosis | 2 | 2018 |
| K01ES025431 | The role of epigenetic heterogeneity in CLL evolution | 2 | 2018 |
| P50CA102701 | Mayo Clinic SPORE in Pancreatic Cancer | 2 | 2018 |
| R01DK102562 | Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac | 2 | 2018 |
| R01HL118462 | p90RSK-ERK5 module, efferocytosis, and vulnerable plaque formation | 2 | 2018 |
| R01HL123346 | PAR 13-233 cART accelerates vascular aging in HIV infected subjects | 2 | 2018 |
| R25CA112355 | Training in Molecular& Genetic Epidemiology of Cancer | 2 | 2018 |
| UM1CA182876 | Cancer epidemiology cohorts in Shanghai and Singapore | 2 | 2018 |
| UM1CA182910 | Shanghai Womens Health Study | 2 | 2018 |
| DP2ES030554 | Revealing somatic genome alterations and their clinical sequelae: Ultrasensitive computational detection of mosaic structural variants | 1 | 2018 |
| F31NS103500 | Molecular mechanisms mediated by ACVR1 G328V and H3K27M in diffuse intrinsic pontine glioma biology | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/grants?page=43